Zobrazeno 1 - 10
of 262
pro vyhledávání: '"A. Woronow"'
Publikováno v:
In Endocrine Practice July 2024 30(7):603-609
Autor:
Anton Pottegård, Rebecca E Ghosh, Robert W Platt, Efe Eworuke, HaNa Lee, Marie C Bradley, Ashish Rai, Peter Bjødstrup Jensen, Mayura Shinde, Laura Hou, Michael J Paterson, Judith C Maro, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Stephen Welburn
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Objectives To examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled.Design Retrospective cohor
Externí odkaz:
https://doaj.org/article/1a9e38df6e294a2abc497e762ff2c878
Autor:
Daniel Woronow, Christine Chamberlain, Ali Niak, Mark Avigan, Monika Houstoun, Cindy Kortepeter
Publikováno v:
JAMA internal medicine. 182(10)
This case series identifies cases reported in the US Food and Drug Administration Adverse Event Reporting System of acute cholecystitis associated with use of glucagon-like peptide-1 receptor agonists that did not have gallbladder disease warnings in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Lecture Notes in Networks and Systems ISBN: 9783031280726
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3165ddd23eb816178120c803abdb075d
https://doi.org/10.1007/978-3-031-28073-3_57
https://doi.org/10.1007/978-3-031-28073-3_57
Autor:
Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley
Publikováno v:
BMJ Open. 13:e070985
ObjectivesTo examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled.DesignRetrospective cohort
Publikováno v:
Journal of the American College of Cardiology. 81:1759
Autor:
Aleksandra Szydlowka, Jaroslaw Smieja, Lukasz Kania, Marcin Pacholczyk, Maciej Cholewa, Adam Galuszka, Eryka Probierz, Kamil Skowronski, Piotr Solarz, Ewa Bajer, Pawel Woronow, Damian Bereska
Publikováno v:
MMAR
Virtual environments (VE) are commonly used in learning or training in many different areas. We are focused on the problem when a group of artificial agents are simulated at the same time; their behavior is easily recognized as ‘artificial’. To a
Autor:
Michelle C, Nadeau Nguyen, Daniel, Woronow, Bailee, Binks, Afrouz, Nayernama, S Christopher, Jones
Publikováno v:
JACC: CardioOncology
Autor:
Michelle Nadeau Nguyen, Laleh Amiri-Kordestani, Daniel Woronow, Afrouz Nayernama, Michael Brave, S. Christopher Jones, Sundeep Agrawal, Connie Cheng
Publikováno v:
Vascular medicine (London, England). 26(5)
The US Food and Drug Administration (FDA) has approved multiple systemic vascular endothelial growth factor (VEGF) inhibitors since 2004 to treat various malignancies. Inhibition of the VEGF signaling pathway can result in impairment of vascular wall